Tag: Quest Diagnostics Drug Testing Index
Drug Testing Index: A look at 2014-2018
The Quest Diagnostics Drug Testing Index reveals insights into patterns of drug use among the U.S. workforce on its 30th anniversary. Download our timeline.
10 facts about opioids
We compiled the most recent data and headlines about substance abuse, addiction, overdose deaths, and health consequences of America's opioid crisis.
Cocaine continues upward trend
Cocaine positivity increased 12% in 2016, reaching a 7-year high of 0.28%, according to the latest Quest Diagnostics Drug Testing Index.
Increases in illicit drugs, including cocaine, drive workforce drug positivity to highest rate in 12 years
The Quest Diagnostics Drug Testing Index shows increases in positivity for illicit drugs, such as marijuana and cocaine, across virtually all test types.
Employers paying the price of substance abuse
Employers can now calculate the cost of substance abuse on their businesses with the Substance Use Cost Calculator.
Revisions to Federal workplace drug testing
HHS revised its mandatory guidelines to expand federal urine drug testing to include hydrocodone, hydromorphone, oxycodone, and oxymorphone.
Data shows escalating drug use in the U.S. workforce
Typically, there is at least 30 percent more self-reported drug use by people who work for an employer without a drug testing program.
Post-accident positivity climbs among American workers
Quest Diagnostics Drug Testing Index data shows a significant increase in positive post-accident drug tests in the American workforce.
By the Numbers: Heroin positivity continues to rise
Heroin positivity increased 146% between 2011 and 2015 in the general U.S. workforce according to the Quest Diagnostics Drug Testing Index.
Navigating global drug testing webinar highlights
Quest Diagnostics experts clear the path towards creating a successful, drug-free workplace program abroad.
